Sang-Ki Kim

5PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 04, 2026
Optimized ex vivo expansion and functional characterization of canine natural killer cells using genetically modified feeder cells.

|Jun 12, 2026
Development of Genetically Modified ARH-77 Feeder Cells for Efficient Expansion of Natural Killer Cells with Potent Anti-Tumor Activity.

|Dec 23, 2022
Chrysin Induces Apoptosis via the MAPK Pathway and Regulates ERK/mTOR-Mediated Autophagy in MC-3 Cells.

Gi-Hwan Jung, Jae-Han Lee, So-Hee Han

|Aug 26, 2022
Selective Expansion of NKG2C+ Adaptive NK Cells Using K562 Cells Expressing HLA-E.

Minh-Trang Thi Phan, Jinho Kim, Seung Kwon Koh

|Oct 16, 2019
Canine non-B, non-T NK lymphocytes have a potential antibody-dependent cellular cytotoxicity function against antibody-coated tumor cells.

Yoseop Kim, Soo-Hyeon Lee, Cheol-Jung Kim

Pageof 1

Frequent Collaborators

1 joint publications

Hyun-Young Kim

1 joint publications

Ji-Youn Jung

1 joint publications

Seung-Hwan Lee

1 joint publications

Yurim An